Therapeuticsmd incorporated

美股醫療保健

TXMD 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

價值面評分優異,但股利評分未超過2分,若公司開始配息,可能會有更優異的投資結果

TXMD 近期報酬表現

-2.56%

Therapeuticsmd incorporated

0.85%

同產業平均

-0.21%

S&P500

與 TXMD 同產業的標的表現

  • RPTX Repare therapeutics inc
    價值 3 分趨勢 1 分波段 2 分籌碼 2 分股利 1 分
    查看更多

TXMD 公司資訊

TherapeuticsMD, Inc. is a healthcare company. The Company is focused on developing and commercializing products exclusively for women. It is engaged in conducting business by out-licensing its products and collecting royalties, after granting a license to commercialize the Company's IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands in the United States and its possessions and territories and assigning the Company's exclusive license to commercialize ANNOVERA in the United States and its possessions and territories to Mayne Pharma. ANNOVERA is a one-year (13 cycles) ring-shaped contraceptive vaginal system (CVS)). ANNOVERA, which is made with a silicone elastomer, contains segesterone acetate, a 19-nor progesterone derivative also known as Nestorone (SA) and ethinyl estradiol (EE). Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.

TXMD 股價